Serum metabolomic signatures of relapse recovery in early multiple sclerosis

Comprehensive Summary

This study, presented by Farren B.S. Briggs et al., examines serum metabolomic signatures that differentiates between relapsing-remitting MS in it's early stages in order to better understand the recovery period. In order to do this, the researchers using serum metabolomic characterization in 79 relapsing-remitting MS patients, through chart review and analyzing recent and non-recent lapses. In order to analyze such relapses, it was done via machine learning in order to show the changes across five stages of relapsing. The researchers found that due to serum metabolomic characterization early in relapse-remitting MS illustrated biochemical changes, which ultimately showed a natural dysfunction in the mitochondrion among other aspects.

Outcomes and Implications

This research is imperative because it uncovers more about neuroinflammation that is a reflection of what types of diseases can happen in the future. By being able to study RRMS in regards to this sense of trajectory, it helps to better understand how to combat certain neuroinflammatory diseases by better understanding their progression and the path to recovery. Overall, research in this particular area paves the way for helping to overall understand the brain and the affects on the brain when threatened.